REGENXBIO Inc.
NASDAQ:RGNX
12.53 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -263.494 | -280.321 | 127.84 | -111.25 | -94.733 | 99.937 | -73.169 | -62.967 | -22.811 | -4.003 | -5.387 |
| Depreciation & Amortization
| 17.32 | 12.909 | 9.564 | 8.407 | 7.152 | 3.982 | 2.686 | 0.544 | 0.08 | 0 | 0 |
| Deferred Income Tax
| -1.144 | 0 | -1.916 | 3.843 | -38.97 | 0.794 | 1.336 | 2.004 | 0.322 | 0 | 0 |
| Stock Based Compensation
| 40.267 | 40.788 | 38.808 | 31.949 | 26.854 | 16.641 | 10.605 | 7.031 | 2.921 | 0.319 | 0 |
| Change In Working Capital
| -10.887 | 13.977 | 40.218 | 14.219 | -5.325 | -7.774 | 0.897 | 5.229 | -3.04 | 1.11 | 2.664 |
| Accounts Receivables
| 3.935 | 4.822 | 14.118 | -9.898 | -8.622 | -16.803 | 0.561 | 1.073 | -1.342 | -0.799 | -0.036 |
| Inventory
| 0 | 0 | 29.303 | 17.85 | 2.369 | 5.346 | -2.199 | 2.82 | -2.508 | 1.723 | 4.889 |
| Accounts Payables
| -2.791 | 18.79 | -2.304 | 3.873 | 1.528 | -0.218 | 2.621 | 0.186 | 0.59 | 0.033 | 0.257 |
| Other Working Capital
| -12.031 | -9.635 | -0.899 | 2.394 | -0.6 | 3.901 | -0.086 | 1.15 | 0.22 | 0.153 | -2.446 |
| Other Non Cash Items
| -0.469 | 5.159 | 4.361 | -1.229 | -2.683 | -8.932 | -0.347 | -0.399 | 0.013 | 0.175 | -0.289 |
| Operating Cash Flow
| -218.407 | -207.488 | 218.875 | -54.061 | -107.705 | 104.648 | -57.992 | -48.558 | -22.515 | -2.399 | -3.012 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -9.96 | -30.724 | -84.175 | -26.869 | -11.72 | -13.278 | -7.16 | -8.149 | -0.522 | 0 | 0 |
| Acquisitions Net
| -1.975 | 0 | -4.991 | -149.628 | -295.984 | -179.71 | -0.479 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -86.564 | -184.875 | -498.144 | -123.041 | -190.735 | -445.829 | -68.634 | -45.072 | -163.278 | 0 | 0 |
| Sales Maturities Of Investments
| 287.467 | 203.67 | 175.677 | 272.669 | 296.014 | 179.749 | 71.004 | 72.609 | 0 | 0 | 0 |
| Other Investing Activites
| 1.975 | 0 | 4.991 | 149.628 | 295.984 | 179.71 | 0.479 | -0.225 | -163.278 | 0 | 0 |
| Investing Cash Flow
| 190.943 | -11.929 | -406.642 | 122.759 | 93.559 | -279.358 | -4.79 | 19.163 | -163.8 | 0 | 0 |
| Financing Activities: | |||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.034 | 0 | 0 |
| Common Stock Issued
| 7.751 | 4.546 | 222.108 | 7.422 | 8.376 | 204.443 | 84.598 | 0.119 | 26.021 | 0 | 0 |
| Common Stock Repurchased
| -0.419 | -0.284 | -0.002 | 1.799 | 1.314 | 0.847 | 0.556 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -34.547 | -28.556 | 195.252 | 200.214 | -1.314 | 204.443 | 84.598 | 0.119 | 213.289 | 2.401 | 1.965 |
| Financing Cash Flow
| -34.966 | -28.84 | 195.25 | 200.214 | 8.376 | 204.443 | 84.598 | 0.119 | 239.31 | 2.401 | 1.965 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -62.43 | -248.257 | 7.483 | 268.912 | -5.77 | 29.733 | 21.816 | -29.276 | 52.995 | 0.002 | -1.047 |
| Cash At End Of Period
| 34.522 | 98.982 | 347.239 | 339.756 | 70.844 | 76.614 | 46.656 | 24.84 | 54.116 | 1.121 | 1.119 |